Naphtho[1,2-d]thiazol-2-ylamine, 95.0%, 1g

6-Bromo-1H-indazole-4-carbonitrile, 95.0%, 250mg

2,4-Dioxo-1,2,3,4-tetrahydroquinazoline-7-carbonitrile, 95.0%, 1g

tert-Butyl (1-hydroxy-3-methylbutan-2-yl)carbamate, 95.0%, 10g

1,3-Di(1-adamantyl)imidazolinium Tetrafluoroborate>98.0%(HPLC)500mg

(6-Formylbenzo[d][1,3]dioxol-5-yl)boronic acid, 95.0%, 1g

DL-Histidine, min. 98.5%, for biochemistry, 25 g, plastic packaging.

(S)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-((1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl)amino)butanoic acid, 97%, 5g

4-Bromo-6-methoxy-1H-indazole, 95.0%, 5g

2-Cyclopropyl-4-fluorobenzaldehyde, 97%, 250mg

1-Bromo-4-decylbenzene, 95.0%, 1g

Pentafluorophenylacetic acid, 96.0%, 25g

1-(4-bromophenyl)-N-ethylpropan-1-amine, 95.0%, 1g